Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers (SEMHF)
OTHER OTC:SEMHF
SEMHF Stock Chart & Stats
$57.75
$0.00(0.00%)
At close: 4:00 PM EST
$57.75
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$46.25 - $61.00
Previous CloseN/A
Volume16.00
Average Volume (3M)2.69K
Market Cap
$58.46B
Enterprise Value$64.36B
Total Cash (Recent Filing)$2.17B
Total Debt (Recent Filing)$15.06B
Price to Earnings (P/E)24.7
Beta0.64
Next Earnings
Feb 05, 2026EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend Yield1.86%
Share Statistics
EPS (TTM)0.80
Shares Outstanding1,128,000,000
10 Day Avg. Volume2,222
30 Day Avg. Volume2,693
Financial Highlights & Ratios
PEG Ratio2.46
Price to Book (P/B)2.86
Price to Sales (P/S)2.20
P/FCF Ratio22.75
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue2.75
Enterprise Value/Gross Profit7.13
Enterprise Value/Ebitda14.04
Forecast
1Y Price Target
$63.79Price Target Upside10.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash FlowFree cash flow was EUR197mn, up 64% y/y, significantly higher than the previous year, supporting continued investment in innovation and shareholder returns.
InnovationSiemens Healthineers is at the forefront of innovation and was the first company to obtain FDA approval for the first photon-counting CT for clinical use and continues to be the only company with such technology commercially available.
Revenue GrowthRevenue grew 6.8% y/y to EUR5.9bn, beating full-year guidance of 5% to 6%.
Bears Say
Competitive AdvantageFirst mover advantage may not last long.
Diagnostics Segment PerformanceDiagnostics revenue growth was modest and the adjusted EBIT was materially below expectations.
Tariffs And Trade BarriersThe adjusted EPS forecast range was widened from EUR2.35 to EUR2.50 originally to EUR2.20 to EUR2.50 to factor in anticipated impacts from tariffs and trade barriers which may affect operations in key markets.
Siemens Healthineers AG News
SEMHF FAQ
What was Siemens Healthineers’s price range in the past 12 months?
Siemens Healthineers lowest stock price was $46.25 and its highest was $61.00 in the past 12 months.
What is Siemens Healthineers’s market cap?
Siemens Healthineers’s market cap is $58.46B.
When is Siemens Healthineers’s upcoming earnings report date?
Siemens Healthineers’s upcoming earnings report date is Feb 05, 2026 which is in 40 days.
How were Siemens Healthineers’s earnings last quarter?
Siemens Healthineers released its earnings results on Nov 05, 2025. The company reported $0.801 earnings per share for the quarter, missing the consensus estimate of $0.809 by -$0.008.
Is Siemens Healthineers overvalued?
According to Wall Street analysts Siemens Healthineers’s price is currently Undervalued.
Does Siemens Healthineers pay dividends?
Siemens Healthineers pays a Annually dividend of $1.176 which represents an annual dividend yield of 1.86%. See more information on Siemens Healthineers dividends here
What is Siemens Healthineers’s EPS estimate?
Siemens Healthineers’s EPS estimate is 0.54.
How many shares outstanding does Siemens Healthineers have?
Siemens Healthineers has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers’s price movement after its last earnings report?
Siemens Healthineers reported an EPS of $0.801 in its last earnings report, missing expectations of $0.809. Following the earnings report the stock price went down -5.87%.
Which hedge fund is a major shareholder of Siemens Healthineers?
Currently, no hedge funds are holding shares in SEMHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$63.79 (10.46% Upside)
$63.79 (10.46% Upside)
Insider Transactions
Bought Shares
Worth $121.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.07%
12-Months-Change
Fundamentals
Return on Equity
11.45%
Trailing 12-Months
Asset Growth
1.43%
Trailing 12-Months
Company Description
Siemens Healthineers
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
SEMHF Company Deck
SEMHF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Siemens Healthineers reported a strong fiscal year 2025 with impressive growth and segment performance. However, challenges in China and macroeconomic headwinds, particularly tariffs and foreign exchange, present significant hurdles for fiscal year 2026. Despite these challenges, the company has laid a solid foundation for future growth and profitability.View all SEMHF earnings summariesSEMHF Stock 12 Month Forecast
Average Price Target
$63.79
▲(10.46% Upside)
Technical Analysis
Carl Zeiss Meditec
―
Fresenius Medical Care AG & Co. KGaA
―
Fresenius SE & Co. KGaA
―
Merck KGaA
―
Sartorius
―
Ownership Overview
― Insiders
2.71% Mutual Funds
― Other Institutional Investors
93.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---